SCHEMBL12102102

SCHEMBL12102102

CC(C)N(C)C[C@@H]1CCCN1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GHSR Q92847 12/20 0.38
▸ CYP2D6 P10635 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ MLNR O43193 1/20 0.36
▸ ABCB11 O95342 1/20 0.36
▸ EGFR P00533 1/20 0.36
▸ FYN P06241 1/20 0.36
▸ CHRM2 P08172 1/20 0.36
▸ CHRM4 P08173 1/20 0.36
▸ HTR1A P08908 1/20 0.36
▸ CHRM5 P08912 1/20 0.36
▸ ADRA2A P08913 1/20 0.36
▸ ADORA3 P0DMS8 1/20 0.36
▸ CHRM1 P11229 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21165727 1.00 GHSR (0.38) GHSRCYP2D6MEN1ALDH1A1LMNA
SCHEMBL26723734 0.94 KMT2A (0.43) GHSRCYP2D6MEN1ALDH1A1LMNA
SCHEMBL9875089 0.94 KMT2A (0.43) GHSRCYP2D6MEN1ALDH1A1LMNA
SCHEMBL10059315 0.79 — —
SCHEMBL1401177 0.79 — —
SCHEMBL588857 0.79 — —
SCHEMBL12339290 0.77 GHSR (0.36) GHSRCYP2D6MEN1ALDH1A1LMNA
Hydrochloric Acid SCHEMBL8177494 0.77 GHSR (0.35) GHSRCYP2D6MEN1ALDH1A1LMNA
Hydrochloric Acid SCHEMBL20520978 0.77 GHSR (0.35) GHSRCYP2D6MEN1ALDH1A1LMNA
Hydrochloric Acid SCHEMBL1190877 0.77 GHSR (0.35) GHSRCYP2D6MEN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9957267-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2018-05-01 — — US disclosed
EP-1756051-B1 Histamine H3 receptor agents, preparation and therapeutic uses LILLY CO ELI (US) 2012-09-12 — — EP disclosed
Send feedback